CYP2A13, CYP2A6, and the risk of lung adenocarcinoma in a Japanese population

Chikako Kiyohara, Koichi Takayama, Yoichi Nakanishi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Both cytochrome P450 (CYP) 2A6 and CYP2A13 are involved in the metabolic activation of tobacco-specific N-nitrosamines (TSNAs). Some kinds of TSNAs induce lung adenocarcinoma in laboratory animals. Thus, polymorphisms of CYP2A6 and CYP2A13 genes may be important as genetic factors of lung cancer, particularly lung adenocarcinoma. We genotyped 179 patients with lung cancer and 183 controls for CYP2A6 gene deletion-type and CYP2A13 C3375T polymorphisms by polymerase chain reaction-based techniques on DNA prepared from peripheral blood. In addition, a questionnaire was used to collect demographic, lifestyle and other information from each subject. Unconditional logistic regression was used to compute the odds ratios (ORs) and their 95% confidence intervals (95% CIs), with adjustments for several covariates found to be associated with risk. Compared with one or more copies of the T allele, the CYP2A13 CC genotype was associated with a substantially increased risk for lung adenocarcinoma (OR = 2.41, 95% CI = 1.03-6.28). Smokers with the CYP2A13 CC genotype showed significantly higher risk (OR = 4.88, 95% CI = 1.35-26.53) compared to non-smokers with possession at least one copy of the CYP2A13 T allele. Although our results indicate that the CYP2A13 gene may play a role in the development of lung adenocarcinoma, the risk for those individuals with single at-risk genotype of CYP2A13 C3375T polymorphism may not be so large. In future studies, analyses based on haplotypes are recommended to confirm the role of CYP2A13 gene in the development of lung adenocarcinoma.

Original languageEnglish
Pages (from-to)658-666
Number of pages9
JournalJournal of Health Science
Volume51
Issue number6
DOIs
Publication statusPublished - Jan 1 2005

Fingerprint

Genes
Polymorphism
Odds Ratio
Lung Neoplasms
Nitrosamines
Tobacco
Population
Genotype
Confidence Intervals
Alleles
Polymerase chain reaction
Gene Deletion
Laboratory Animals
Cytochrome P-450 Enzyme System
Haplotypes
Logistics
Life Style
Animals
Blood
Logistic Models

All Science Journal Classification (ASJC) codes

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

CYP2A13, CYP2A6, and the risk of lung adenocarcinoma in a Japanese population. / Kiyohara, Chikako; Takayama, Koichi; Nakanishi, Yoichi.

In: Journal of Health Science, Vol. 51, No. 6, 01.01.2005, p. 658-666.

Research output: Contribution to journalArticle

Kiyohara, Chikako ; Takayama, Koichi ; Nakanishi, Yoichi. / CYP2A13, CYP2A6, and the risk of lung adenocarcinoma in a Japanese population. In: Journal of Health Science. 2005 ; Vol. 51, No. 6. pp. 658-666.
@article{832d4bbefa6a4d5a994f3826d612479b,
title = "CYP2A13, CYP2A6, and the risk of lung adenocarcinoma in a Japanese population",
abstract = "Both cytochrome P450 (CYP) 2A6 and CYP2A13 are involved in the metabolic activation of tobacco-specific N-nitrosamines (TSNAs). Some kinds of TSNAs induce lung adenocarcinoma in laboratory animals. Thus, polymorphisms of CYP2A6 and CYP2A13 genes may be important as genetic factors of lung cancer, particularly lung adenocarcinoma. We genotyped 179 patients with lung cancer and 183 controls for CYP2A6 gene deletion-type and CYP2A13 C3375T polymorphisms by polymerase chain reaction-based techniques on DNA prepared from peripheral blood. In addition, a questionnaire was used to collect demographic, lifestyle and other information from each subject. Unconditional logistic regression was used to compute the odds ratios (ORs) and their 95{\%} confidence intervals (95{\%} CIs), with adjustments for several covariates found to be associated with risk. Compared with one or more copies of the T allele, the CYP2A13 CC genotype was associated with a substantially increased risk for lung adenocarcinoma (OR = 2.41, 95{\%} CI = 1.03-6.28). Smokers with the CYP2A13 CC genotype showed significantly higher risk (OR = 4.88, 95{\%} CI = 1.35-26.53) compared to non-smokers with possession at least one copy of the CYP2A13 T allele. Although our results indicate that the CYP2A13 gene may play a role in the development of lung adenocarcinoma, the risk for those individuals with single at-risk genotype of CYP2A13 C3375T polymorphism may not be so large. In future studies, analyses based on haplotypes are recommended to confirm the role of CYP2A13 gene in the development of lung adenocarcinoma.",
author = "Chikako Kiyohara and Koichi Takayama and Yoichi Nakanishi",
year = "2005",
month = "1",
day = "1",
doi = "10.1248/jhs.51.658",
language = "English",
volume = "51",
pages = "658--666",
journal = "Journal of Health Science",
issn = "1344-9702",
publisher = "Pharmaceutical Society of Japan",
number = "6",

}

TY - JOUR

T1 - CYP2A13, CYP2A6, and the risk of lung adenocarcinoma in a Japanese population

AU - Kiyohara, Chikako

AU - Takayama, Koichi

AU - Nakanishi, Yoichi

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Both cytochrome P450 (CYP) 2A6 and CYP2A13 are involved in the metabolic activation of tobacco-specific N-nitrosamines (TSNAs). Some kinds of TSNAs induce lung adenocarcinoma in laboratory animals. Thus, polymorphisms of CYP2A6 and CYP2A13 genes may be important as genetic factors of lung cancer, particularly lung adenocarcinoma. We genotyped 179 patients with lung cancer and 183 controls for CYP2A6 gene deletion-type and CYP2A13 C3375T polymorphisms by polymerase chain reaction-based techniques on DNA prepared from peripheral blood. In addition, a questionnaire was used to collect demographic, lifestyle and other information from each subject. Unconditional logistic regression was used to compute the odds ratios (ORs) and their 95% confidence intervals (95% CIs), with adjustments for several covariates found to be associated with risk. Compared with one or more copies of the T allele, the CYP2A13 CC genotype was associated with a substantially increased risk for lung adenocarcinoma (OR = 2.41, 95% CI = 1.03-6.28). Smokers with the CYP2A13 CC genotype showed significantly higher risk (OR = 4.88, 95% CI = 1.35-26.53) compared to non-smokers with possession at least one copy of the CYP2A13 T allele. Although our results indicate that the CYP2A13 gene may play a role in the development of lung adenocarcinoma, the risk for those individuals with single at-risk genotype of CYP2A13 C3375T polymorphism may not be so large. In future studies, analyses based on haplotypes are recommended to confirm the role of CYP2A13 gene in the development of lung adenocarcinoma.

AB - Both cytochrome P450 (CYP) 2A6 and CYP2A13 are involved in the metabolic activation of tobacco-specific N-nitrosamines (TSNAs). Some kinds of TSNAs induce lung adenocarcinoma in laboratory animals. Thus, polymorphisms of CYP2A6 and CYP2A13 genes may be important as genetic factors of lung cancer, particularly lung adenocarcinoma. We genotyped 179 patients with lung cancer and 183 controls for CYP2A6 gene deletion-type and CYP2A13 C3375T polymorphisms by polymerase chain reaction-based techniques on DNA prepared from peripheral blood. In addition, a questionnaire was used to collect demographic, lifestyle and other information from each subject. Unconditional logistic regression was used to compute the odds ratios (ORs) and their 95% confidence intervals (95% CIs), with adjustments for several covariates found to be associated with risk. Compared with one or more copies of the T allele, the CYP2A13 CC genotype was associated with a substantially increased risk for lung adenocarcinoma (OR = 2.41, 95% CI = 1.03-6.28). Smokers with the CYP2A13 CC genotype showed significantly higher risk (OR = 4.88, 95% CI = 1.35-26.53) compared to non-smokers with possession at least one copy of the CYP2A13 T allele. Although our results indicate that the CYP2A13 gene may play a role in the development of lung adenocarcinoma, the risk for those individuals with single at-risk genotype of CYP2A13 C3375T polymorphism may not be so large. In future studies, analyses based on haplotypes are recommended to confirm the role of CYP2A13 gene in the development of lung adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=28544447343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28544447343&partnerID=8YFLogxK

U2 - 10.1248/jhs.51.658

DO - 10.1248/jhs.51.658

M3 - Article

AN - SCOPUS:28544447343

VL - 51

SP - 658

EP - 666

JO - Journal of Health Science

JF - Journal of Health Science

SN - 1344-9702

IS - 6

ER -